MELISSA BROWN: Open Payments
NPI 1720574643 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 20 payments from 11 companies in 2025. Trend: 2023 $228 · 2024 $300 · 2025 $534
Food & beverage: $499Education: $35
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $165 |
| Janssen Biotech, Inc. | 3 | $66 |
| COLOPLAST CORP | 2 | $52 |
| ABBVIE INC. | 3 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Endo USA, Inc. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
| Ferring Pharmaceuticals Inc. | 1 | $25 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $22 |
| UROGEN PHARMA, INC. | 1 | $20 |
Products named: Axonics, ERLEADA, LUPRON DEPOT, ORGOVYX, XIAFLEX, IMFINZI, ADSTILADRIN, JOURNAVX.
Industry payments across MO — which companies pay providers there.
